Transcription of The U.S. Biosimilars Market
{{id}} {{{paragraph}}}
Example: dental hygienist
The U.S. Biosimilars Market
Threats and OpportunitiesThe Biosimilars MarketDe a n & Co m p a n ySt r a t e g y Co nSu l t a n tSli f e SCi e nCeSDean & Company is a strategy consulting firm with a unique mix of both traditional business strategy development and a range of investing advisory work; our clients include large corporations, technology start-ups, and private equity funds. We work with senior executives to dramatically and sustainably improve their company s performance, often in situations where they are facing new, complex, and unstructured problems or opportunities. Our fact-based, analytical, and hands-on approach, combined with our commitment to create actionable solutions and to work with our clients to see them through implementation, provides a compelling and unique value proposition.
22 The U.S. Biosimilars Market product pharmaceutically. Given the complex nature of protein products and the manufacturing processes that produce them, it is no wonder that debate exists about
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: